Advisor Group Holdings, Inc. Inmune Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 5,115 shares of INMB stock, worth $7,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,115

Previous 12,510 59.11%

Holding current value

$7,416

Previous $28,000 64.29%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.76 - $2.91 $13,015 - $21,519	-7,395 Reduced 59.11%	5,115 $10,000
Q2 2025 Sep 04, 2025	BUY	$2.31 - $8.26 $22,314 - $79,791	9,660 Added 338.95%	12,510 $28,000
Q2 2025 Aug 13, 2025	SELL	$2.31 - $8.26 $25,583 - $91,479	-11,075 Reduced 79.53%	2,850 $6,000
Q1 2025 May 12, 2025	BUY	$4.93 - $10.48 $57,311 - $121,830	11,625 Added 505.43%	13,925 $108,000
Q4 2024 Jun 06, 2025	SELL	$4.4 - $6.43 $51,150 - $74,748	-11,625 Reduced 83.48%	2,300 $10,000

Q4 2024 Feb 07, 2025	SELL	$4.4 - $6.43 $19,360 - $28,292	-4,400 Reduced 65.67%	2,300 $10,000
Q3 2024 Nov 13, 2024	SELL	$4.86 - $9.86 $7,110 - $14,425	-1,463 Reduced 17.92%	6,700 $36,000
Q2 2024 Aug 13, 2024	SELL	$7.15 - $11.84 $29,365 - $48,626	-4,107 Reduced 33.47%	8,163 $71,000
Q1 2024 May 10, 2024	BUY	$10.53 - $14.01 $16,532 - $21,995	1,570 Added 14.67%	12,270 $144,000
Q4 2023 Feb 12, 2024	BUY	$6.6 - $11.52 $14,520 - $25,344	2,200 Added 25.88%	10,700 $120,000
Q3 2023 Nov 13, 2023	SELL	$6.61 - $10.9 $17,847 - $29,430	-2,700 Reduced 24.11%	8,500 $57,000
Q2 2023 Aug 10, 2023	BUY	$6.5 - $10.09 $21,222 - $32,943	3,265 Added 41.15%	11,200 $101,000
Q1 2023 May 12, 2023	SELL	$6.01 - $10.18 $7,903 - $13,386	-1,315 Reduced 14.22%	7,935 $51,000
Q4 2022 Feb 10, 2023	BUY	$6.13 - $7.96 $19,616 - $25,472	3,200 Added 52.89%	9,250 $58,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $10.44 $2,977 - $5,146	493 Added 8.87%	6,050 $38,000
Q2 2022 Aug 10, 2022	SELL	$5.48 - $8.97 $150,935 - $247,060	-27,543 Reduced 83.21%	5,557 $49,000
Q1 2022 May 04, 2022	BUY	$6.42 - $11.39 $134,370 - $238,392	20,930 Added 171.98%	33,100 $279,000
Q3 2021 Nov 05, 2021	SELL	$14.13 - $27.85 $213,249 - $420,312	-15,092 Reduced 55.36%	12,170 $237,000
Q2 2021 Aug 02, 2021	BUY	$9.29 - $19.33 $179,111 - $372,682	19,280 Added 241.54%	27,262 $479,000
Q1 2021 May 13, 2021	BUY	$11.61 - $26.85 $23,011 - $53,216	1,982 Added 33.03%	7,982 $94,000
Q3 2020 Nov 12, 2020	BUY	$4.92 - $15.75 $28,536 - $91,350	5,800 Added 2900.0%	6,000 $62,000
Q2 2020 Aug 14, 2020	SELL	$3.1 - $6.09 $310 - $609	-100 Reduced 33.33%	200 $1,000
Q1 2020 May 18, 2020	BUY	$2.21 - $6.15 $663 - $1,845	300 New	300 $1,000

Others Institutions Holding INMB

# of Institutions

Shares Held

5.36M

Call Options Held

310K

Put Options Held

371K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $26M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Inmune Bio, Inc. Transaction History